Phase II evaluation of pyrazofurin in patients with carcinoma of the lung

Cancer Treat Rep. 1978 Mar;62(3):451-2.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adult
  • Aged
  • Amides
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy
  • Clinical Trials as Topic
  • Drug Evaluation
  • Humans
  • Lung Neoplasms / drug therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Pyrazoles
  • Ribonucleosides / adverse effects
  • Ribonucleosides / therapeutic use*
  • Ribose

Substances

  • Amides
  • Antibiotics, Antineoplastic
  • Pyrazoles
  • Ribonucleosides
  • pyrazofurin
  • Ribose